The complement system is a humoral immuno-effector system present in blood plasma that consists of about 20 plasma proteins. The final outcome of complement activation is the formation of the membrane attack complex (MAC) on target cell membranes. The MAC assembles by the sequential fusion of five hydrophilic proteins (C5b through C9) to form an integral transmembrane pore complex. The focus of this grant proposal is the investigation of the structures and functions of two of the five proteins that comprise the MAC, namely C6 and C7, Since a transition from a soluble state to a membrane bound intermediate occurs after C7 adds to C5b-6, the studies on C6 and C7 provide an opportunity to discern the molecular mechanism of membrane binding and penetration by the late acting proteins of complement. The scope of proposed research calls for obtaining structural information about C6,C7 and their complexes at several levels of organization. The immediate priority is to complete the important regions in these proteins that are involved in subunit interaction and membrane binding. The outcome of this research should provide a detailed account of the early events in the assembly of the MAC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022415-05
Application #
3133441
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1985-07-01
Project End
1992-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
5
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
DiScipio, R G; Daffern, P J; Jagels, M A et al. (1999) A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162:1127-36
DiScipio, R G; Linton, S M; Rushmere, N K (1999) Function of the factor I modules (FIMS) of human complement component C6. J Biol Chem 274:31811-8
DiScipio, R G; Berlin, C (1999) The architectural transition of human complement component C9 to poly(C9). Mol Immunol 36:575-85
Sriramarao, P; DiScipio, R G (1999) Deposition of complement C3 and factor H in tissue traumatized by burn injury. Immunopharmacology 42:195-202
Borgstrom, P; Discipio, R; Maione, T E (1998) Recombinant platelet factor 4, an angiogenic marker for human breast carcinoma. Anticancer Res 18:4035-41
Discipio, R G; Jenner, L; Thirup, S et al. (1998) Crystallization of human complement component C5. Acta Crystallogr D Biol Crystallogr 54:643-6
Lengweiler, S; Schaller, J; DiScipio, R G et al. (1997) Elucidation of the disulfide-bonding pattern in the factor I modules of the sixth component (C6) of human complement. Biochim Biophys Acta 1342:13-8
van Dixhoorn, M G; Timmerman, J J; Van Gijlswijk-Janssen, D J et al. (1997) Characterization of complement C6 deficiency in a PVG/c rat strain. Clin Exp Immunol 109:387-96
DiScipio, R G (1996) Preparation of colloidal gold particles of various sizes using sodium borohydride and sodium cyanoborohydride. Anal Biochem 236:168-70
Sriramarao, P; Norton, C R; Borgstrom, P et al. (1996) E-selectin preferentially supports neutrophil but not eosinophil rolling under conditions of flow in vitro and in vivo. J Immunol 157:4672-80

Showing the most recent 10 out of 19 publications